These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12202977)

  • 1. Therapeutic strategies for colorectal cancer in Europe and the United States: focus on chemotherapy for advanced colorectal cancer.
    Bennouna J; Douillard JY
    Int J Clin Oncol; 2002 Aug; 7(4):236-44. PubMed ID: 12202977
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent developments on the integration of biologic agents with cytotoxic chemotherapy in the treatment of advanced colorectal cancer.
    Chu E
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S46. PubMed ID: 19064405
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of advanced colorectal and gastric cancer with 5-fluorouracil and calcium n-methyltetrahydrofolate.
    Casali A; Tonachella R; Tropea F; Verri C; Paoletti G; Gionfra T; Modugno G; Gallo Curcio C
    J Chemother; 1989 Jul; 1(4 Suppl):1212-4. PubMed ID: 16312838
    [No Abstract]   [Full Text] [Related]  

  • 4. Evolution of systemic therapy for metastatic colorectal cancer.
    Geh JI; Ma YT
    Colorectal Dis; 2011 Aug; 13(8):852-4. PubMed ID: 21762349
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy culture differences persist, but molecular insights foster change.
    Benowitz S
    J Natl Cancer Inst; 2012 Apr; 104(8):576-8. PubMed ID: 22472544
    [No Abstract]   [Full Text] [Related]  

  • 6. [Conversion therapy for colorectal cancer].
    Sasaki N; Yoshino T
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1793-7. PubMed ID: 22164897
    [No Abstract]   [Full Text] [Related]  

  • 7. OPTIMOX1 in advanced colorectal cancer: lack of evidence for a stop-and-go strategy.
    Rosa DD; Ismael GF; de Azambuja E; Braga S; Cardoso F; Bleiberg H
    J Clin Oncol; 2006 Nov; 24(32):5176-7; author reply 5177. PubMed ID: 17093286
    [No Abstract]   [Full Text] [Related]  

  • 8. First-line treatment options for patients with metastatic colorectal cancer.
    Schilsky RL
    Nat Clin Pract Oncol; 2004 Dec; 1(2):70-1. PubMed ID: 16264820
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic strategies in colorectal cancer].
    Flieger D; Keller R; Fischbach W
    Dtsch Med Wochenschr; 2003 Sep; 128(37):1902-7. PubMed ID: 12970825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Adjuvant therapeutic procedures in colorectal cancer: indications and possibilities].
    Porschen R; Bermann A
    Z Gastroenterol; 1993 Nov; 31 Suppl 5():35-8. PubMed ID: 8197798
    [No Abstract]   [Full Text] [Related]  

  • 11. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First-line chemotherapy for unresectable and metastatic colorectal cancer].
    Satoh T
    Gan To Kagaku Ryoho; 2014 Nov; 41(11):1372-5. PubMed ID: 25577805
    [No Abstract]   [Full Text] [Related]  

  • 13. [A review of FOLFOXIRI chemotherapy for the 1st line treatment of metastatic colorectal cancer].
    Kawakami H; Satoh T; Nakagawa K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():439-45. PubMed ID: 22214001
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
    Sugimoto M; Yasuda H; Koda K; Yamazaki M; Tezuka T; Takenoue T; Kosugi C; Higuchi R; Yamamoto S; Watayo Y; Yagawa Y; Suzuki M
    Hepatogastroenterology; 2007 Sep; 54(78):1684-8. PubMed ID: 18019695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Does an effective adjuvant treatment in colorectal cancer exist?].
    Díaz-Rubio E
    Rev Clin Esp; 1993 Feb; 192(2):59-61. PubMed ID: 8460235
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy: Evaluation of Masi G, Loupakis F, Salvatore L, et al. Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial. Lancet Oncol 2010;11:845-52.
    Bruera G; Ricevuto E
    Expert Opin Biol Ther; 2011 Jun; 11(6):821-4. PubMed ID: 21545334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of advanced colorectal cancer].
    Schalhorn A
    Fortschr Med; 1991 Mar; 109(8):183-6. PubMed ID: 2055582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in the treatment of advanced colorectal cancer].
    Díaz-Rubio E
    Rev Clin Esp; 1990 Apr; 186(6):292-300. PubMed ID: 1697421
    [No Abstract]   [Full Text] [Related]  

  • 19. [Is there a reliable adjuvant (intraoperative) chemotherapy of colorectal cancer?].
    Hossfeld DK
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():175-8. PubMed ID: 1983550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update for surgeons: recent and noteworthy changes in therapeutic regimens for cancer of the colon and rectum.
    Hriesik C; Ramanathan RK; Hughes SJ
    J Am Coll Surg; 2007 Sep; 205(3):468-78 (Quiz 524). PubMed ID: 17765164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.